Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermExcel is a medical-grade skincare company based in South Africa that specializes in cosmeceutical products formulated for specific dermatological conditions. Founded by Dr. Hardie de Beer, the company focuses on evidence-based ingredients to treat acne, hyperpigmentation, and signs of aging. Their product range includes chemical peels, serums, and topical treatments designed for use under professional guidance or as part of a structured home-care regimen. DermExcel bridges the gap between over-the-counter cosmetics and prescription-strength dermatological interventions. The company emphasizes high concentrations of active ingredients such as retinol, salicylic acid, and vitamin C to achieve therapeutic outcomes. Its business model primarily involves distribution through medical aesthetic clinics and a direct-to-consumer e-commerce platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermExcel.